Quick Search:

uzh logo
Browse by:
bullet
bullet
bullet
bullet

Zurich Open Repository and Archive 

Permanent URL to this publication: http://dx.doi.org/10.5167/uzh-31350

Fluri, F; Hatz, F; Rutgers, M P; Georgiadis, D; Sekoranja, L; Schwegler, G; Sarikaya, H; Weder, B; Müller, F; Lüthy, R; Arnold, M; Reichhart, M; Mattle, H P; Tettenborn, B; Nedeltchev, K; Hungerbühler, H J; Sztajzel, R; Baumgartner, R W; Michel, P; Lyrer, P A; Engelter, S T (2010). Intravenous thrombolysis in patients with stroke attributable to small artery occlusion. European Journal of Neurology, 17(8):1054-1060.

[img]
Preview
Accepted Version
PDF
1MB
[img] PDF - Registered users only
88kB

Abstract

Background: Intravenous thrombolysis (IVT) for stroke seems to be beneficial independent of the underlying etiology. Recent observations raised concern that IVT might cause harm in patients with strokes attributable to small artery occlusion (SAO). Objective: The safety of IVT in SAO-patients is addressed in this study. Methods: We used the Swiss IVT databank to compare outcome and complications of IVT-treated SAO-patients with IVT-treated patients with other etiologies (non-SAO-patients). Main outcome and complication measures were independence (modified Rankin scale </=2) at 3 months, intracranial hemorrhage (ICH), and recurrent ischaemic stroke. Results: Sixty-five (6.2%) of 1048 IVT-treated patients had SAO. Amongst SAO-patients, 1.5% (1/65) patients died, compared to 11.2% (110/983) in the non-SAO-group (P = 0.014). SAO-patients reached independence more often than non-SAO-patients (75.4% versus 58.9%; OR 2.14 (95% CI 1.20-3.81; P = 0.001). This association became insignificant after adjustment for age, gender, and stroke severity (OR 1.41 95% CI 0.713-2.788; P = 0.32). Glucose level and (to some degree) stroke severity but not age predicted 3-month-independence in IVT-treated SAO-patients. ICHs (all/symptomatic) were similar in SAO- (12.3%/4.6%) and non-SAO-patients (13.4%/5.3%; P > 0.8). Fatal ICH occurred in 3.3% of the non-SAO-patients but none amongst SAO-patients. Ischaemic stroke within 3 months after IVT reoccurred in 1.5% of SAO-patients and in 2.3% of non-SAO-patients (P = 0.68). Conclusion: IVT-treated SAO-patients died less often and reached independence more often than IVT-treated non-SAO-patients. However, the variable 'SAO' was a dependent rather than an independent outcome predictor. The absence of an excess in ICH indicates that IVT seems not to be harmful in SAO-patients.

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Clinic for Neurology
DDC:610 Medicine & health
Language:English
Date:August 2010
Deposited On:01 Mar 2010 08:01
Last Modified:27 Nov 2013 19:01
Publisher:Wiley-Blackwell
ISSN:1351-5101
Publisher DOI:10.1111/j.1468-1331.2010.02961.x
PubMed ID:20136649
Citations:Web of Science®. Times Cited: 7
Google Scholar™
Scopus®. Citation Count: 7

Users (please log in): suggest update or correction for this item

Repository Staff Only: item control page